v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   224,848,992      
Beginning balance at Dec. 31, 2024 $ (49,185) $ 2 $ 1,629,167 $ 6 $ (1,678,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of issuance costs (in shares)   34,437,364      
Issuance of common stock, net of    issuance costs 64,907   64,907    
Proceeds from sale of stock under employee stock purchase plan (in shares)   93,362      
Proceeds from sale of stock under    employee stock purchase plan 78   78    
Exercise of options (in shares)   604,325      
Exercise of options 482   482    
Stock-based compensation expense 2,187   2,187    
Restricted stock unit vesting (in shares)   1,660,547      
Net income (loss) 6,112       6,112
Ending balance (in shares) at Mar. 31, 2025   261,644,590      
Ending balance at Mar. 31, 2025 $ 24,581 $ 2 1,696,821 6 (1,672,248)
Beginning balance (in shares) at Dec. 31, 2025 265,424,818 265,424,818      
Beginning balance at Dec. 31, 2025 $ 32,610 $ 2 1,716,307 6 (1,683,705)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from sale of stock under employee stock purchase plan (in shares)   96,347      
Proceeds from sale of stock under    employee stock purchase plan $ 131   131    
Exercise of options (in shares) 28,424 28,424      
Exercise of options $ 20   20    
Stock-based compensation expense 3,668   3,668    
Restricted stock unit vesting (in shares)   2,348,826      
Net income (loss) $ (9,054)       (9,054)
Ending balance (in shares) at Mar. 31, 2026 267,898,415 267,898,415      
Ending balance at Mar. 31, 2026 $ 27,375 $ 2 $ 1,720,126 $ 6 $ (1,692,759)